Multimodal imaging evaluation of hypertrophic cardiomyopathy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047335

Enrollment

Unknown

Registered

2021-06-12

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic cardiomyopathy

Interventions

hypertrophic cardiomyopathy group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: From July 1, 2021 to December 31, 2023, 100 patients with hypertrophic cardiomyopathy were diagnosed in the Department of Ultrasound Medicine of Wuhan Union Medical College Hospital.

Exclusion criteria

Exclusion criteria: Poor image quality

Design outcomes

Primary

Measure	Time frame
Myocardial fibrosisn parameters;Echocardiography strain parameters;MRI strain parameters;	—

Countries

China

Contacts

Public ContactXie Mingxing

Union Hospital, Tongji Medical College, Huazhong University of Science and Tecnology

xiemx@hust.edu.cn+86 13607108938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026